Not available
Quote | Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
Last: | $1.70 |
---|---|
Change Percent: | 0.0% |
Open: | $1.61 |
Close: | $1.70 |
High: | $1.7 |
Low: | $1.61 |
Volume: | 742 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS PR Newswire Growing data shows intravenous ibuprofen is safe and effective for the treatment of pain and fever in adults, children and infants NASHVILLE, Tenn. , Ap...
2024-03-05 22:06:02 ET Cumberland Pharmaceuticals Inc. (CPIX) Q4 2023 Earnings Conference Call March 05 2024 04:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A. J. Kazimi - Chairman and Chief Executive Officer Todd Anthony - Vice P...
Message Board Posts | Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CPIX News Article - CUMBERLAND PHARMACEUTICALS APPOINTS MARTIN BROWN JR. TO ITS BOARD | whytestocks | investorshangout | 07/19/2022 5:26:01 PM |
Hello Out "There", | bidaskme | investorshub | 07/04/2022 6:23:59 PM |
Historic short interest - | XenaLives | investorshub | 05/16/2022 7:46:50 AM |
whytestocks: $CPIX News Article - Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement wi | whytestocks | investorshangout | 05/09/2022 2:55:50 PM |
whytestocks: $CPIX News Article - TABUK AND CUMBERLAND PARTNER TO BRING INNOVATIVE ANTIBIOTIC WITH L | whytestocks | investorshangout | 03/31/2022 2:30:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Cumberland Pharmaceuticals Inc. Company Name:
CPIX Stock Symbol:
NASDAQ Market:
Cumberland Pharmaceuticals Inc. Website:
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS PR Newswire Growing data shows intravenous ibuprofen is safe and effective for the treatment of pain and fever in adults, children and infants NASHVILLE, Tenn. , Ap...
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results PR Newswire 2023 highlights include expanded FDA approval and new study publications NASHVILLE, Tenn. , March 5, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a sp...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...